Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm

The deal could end a years-long legal battle over the OxyContin maker's role in the US opioid crisis.

Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm

OxyContin-maker Purdue Pharma can settle claims against it by paying up to $7.4 billion to end cases filed amid the nation's opioid epidemic.

El caso, que lleva 20 años en los tribunales, supondrá la desaparición de la farmacéutica y la creación de otra empresa que se dedicará a tratar la adicción

The deal is expected to be one of the largest settlements against an opioid manufacturer, with funds for victims.